Case ID: f-supp_322/html/1011-01.html
Source: Caselaw Access Project
Author: {"author": "PER CURIAM.", "license": "Public Domain", "url": "https://static.case.law/"}
Date Created: 2024-08-24T03:29:51.129683

In re ORAL CONTRACEPTIVES PRODUCTS Liability Litigation.
    No. 62.
    Judicial Panel on Multidistrict Litigation.
    Feb. 18, 1971.
    Before ALFRED P. MURRAH, Chairman*, and JOHN MINOR WISDOM, EDWARD WEINFELD, EDWIN A. ROBSON, WILLIAM H. BECKER, JOSEPH S. LORD, III , and STANLEY A. WEIGEL, Judges of the Panel.
    
      
       Judges Murrah and Lord were unable to attend the hearing but with the consent of all parties they have participated in this decision on the basis of the transcript of the hearing and the pleadings filed in this matter.
    
   OPINION AND ORDER

PER CURIAM.

The House Judiciary Committee Report recommending the passage of S. 159, which established the Judicial Panel on Multidistrict Litigation and added Section 1407 to Title 28 of the United States Code, noted that

* * * The types of cases in which massive filings of multidistrict litigation are reasonably certain to occur include not only civil antitrust actions but also, common disaster (air crash) actions, patent and trademark suits, products liability actions, and securities law violations actions, among others. [Emphasis Added]

Although the Panel has known of the existence of several groups of product liability litigation during the past two years, none has seemed appropriate for transfer under Section 1407.

The Panel recently became aware of the extensive litigation involving the use and alleged side effects of oral contraceptives. The statistics compiled by the Administrative Office of the United States Courts revealed that there were more than twenty recent actions brought against one manufacturer, G. D. Searle & Company, resulting from the use of one or more of its oral contraceptive products. The Panel therefore entered an order directing the parties to show cause why the cases listed on the attached Schedule A should not be transferred for coordinated or consolidated pretrial proceedings, under 28 U.S.C. § 1407. A second order was entered setting this matter for hearing in San Francisco on January 22, 1971.

In their written responses and at the hearing, the parties unanimously contend that there are few if any common questions of fact among these cases and that transfer of any of these cases would not serve the convenience of the parties and their witnesses. In the absence of a showing that there are common questions of fact among the cases to be transferred and that such a transfer would serve the convenience of the parties and their witnesses and promote the just and efficient conduct of the entire litigation, there can, of course, be no transfer under Section 1407. Our decision not to transfer any of these actions at the present time is without prejudice to the right of any party to later move for transfer of any or all of these cases or of the Panel to reconsider transfer on its own initiative.

Transfer denied.

SCHEDULE A

Eastern District of California

Audrey L. Brush & James Brush v. G. D. Searle & Co.

CIVIL ACTION No. Civ. S-1644

Consuelo Ramirez & Juan Ramirez v. G. D. Searle & Co., et al.

CIVIL ACTION No. Civ. S-1764

Patricia Carter McCoy & Freddie McCoy v. G. D. Searle & Co.

CIVIL ACTION No. Civ. S-1771

District of Connecticut

Norbert W. St. Martin, etc. v. G. D. Searle & Co. (Est. of Phyllis Seaton)

CIVIL ACTION No. 13909

Ruth Jean Olsen v. G. D. Searle & Co.

CIVIL ACTION B-138

Cynthia O’Hara v. G. D. Searle & Co.

CIVIL ACTION B-155

District of Kansas

Amelia Ramsey v. G. D. Searle & Co.

CIVIL ACTION No. W-4206

Eastern District of Michigan

Sandra Jane Pennanen & Allan Pennanen v. G. D. Searle & Co.

CIVIL ACTION No. 30765

Rosemary Fitzpatrick & James Fitzpatrick v. G. D. Searle & Co.

CIVIL ACTION No. 35325

District of Nebraska

Juanita Jo McCartney v. G. D. Searle & Co.

CIVIL ACTION No. Civ. 03153

Nancy J. Searcy v. G. D. Searle & Co.

CIVIL ACTION No. Civ. 03602

District of New Jersey

Marilyn Tabatchnick & Jay Tabatchnick v. G. D. Searle & Co., et al.

CIVIL ACTION No. 758-70

Willie Gray, Sr., etc. v. G. D. Searle & Co., et al.

CIVIL ACTION No. 1133-70

Western District of New York

Edward F. Urban & Camille C. Urban v. G. D. Searle & Co.

CIVIL ACTION No. Civ — 1970-39

Edward C. Cranford & Beverly Cranford v. G. D. Searle & Co., et al.

CIVIL ACTION No. Civ.-1970 — 195

Southern District of Ohio

Harry Seyfang v. G. D. Searle & Co., et al.

CIVIL ACTION No. Civil 3684

Marvene A. Seyfang v. G. D. Searle & Co., et al.

CIVIL ACTION No. Civil 3683

Sadie Hotchkiss v. G. D. Searle & Co.

CIVIL ACTION No. Civil 7205

District of Rhode Island

Sandra Oresman & Richard Oresman v. G. D. Searle & Co.

CIVIL ACTION No. Civil 4205

Western District of Texas

Gary L. Hancock & Nancy Hancock v. G. D. Searle & Co.

CIVIL ACTION No. SA 70 CA 130 
      
      . House Report No. 1130, p. 3 (February 28, 1968).
     
      
      . For example, the Panel was aware of the existence of the multidistrict litigation involving Arelen and MER 29 but since many of these cases had been commenced long before the Panel was created, it did not appear that the benefits of Section 1407 would result from the transfer of these cases.
     
      
      . If transfer of these cases was found to be appropriate, the Panel would have considered similar actions now pending against manufacturers of other oral contraceptives.
     
      
      . Although some of these cases had been started more than a year ago, it appeared that the bulk of them had been commenced witliin the past year, possibly as a result of the adverse publicity the Pill has received in recent months. The Panel attempted to exclude the older cases from its order to show cause.
     
      
      . We are not unaware that other drug cases have involved common questions of fact relating to dangerousness, duty to warn, and method of notice. See Basko v. Sterling Drug, Inc., 416 F.2d 417 (2d Cir. 1969); Kershaw v. Sterling Drug, Inc., 415 F.2d 1009 (5th Cir. 1969); Schenebeck v. Sterling Drug, Inc., 423 F.2d 919 (8th Cir. 1970); and Sterling Drug, Inc. v. Yarrow, 408 F.2d 978 (8th Cir. 1969),